행사
2026년 9월 07 – 09일
Advanced Therapies Europe
Barcelona, Spain

Exhibitor, booth 56
Bronze Sponsor
Panel Leadership – From Early Development to Commercial Readiness: Real-World Lessons in Advancing Lentiviral-Based Therapies | September 09, 1:30 PM – 2:30 PM
Moderator: Patricio Massera, President & Board Member, VIVEbiotech.
Speakers:
- Natalia Elizalde, PhD. Chief Business Development Officer, VIVEbiotech.
- Miguel Forte, MD, PhD. CEO, Kiji Therapeutics.
- Willem-Jan Krebber, Mbiotech, MSc, Chief Development Officer, Genewity Holding B.V.
2026년 9월 29 – 01일
BIOSPAIN
Bilbao, Spain

Bronze Sponsor
Participation in two roundtables:
- Making ATMPs Sustainable in 2026: What Gets Funded, Scaled, and Acquired? | September 29, 4:00 – 4:45 PM | VIVEbiotech speaker: Jon Alberdi, CEO.
- From Platform to Patient: Scaling Biotech and Advanced Therapies Through Integrated CDMO Ecosystems | September 30, 11:30 AM–12:15 PM | VIVEbiotech speaker: Natalia Elizalde, PhD, Chief Business Development Officer.
2026년 5월 11 – 15일
ASGCT Annual Meeting
Boston, USA

Exhibitor, booth 1619
Company Presentation Shaping the Future of Lentiviral Vector Manufacturing: Versatile Platforms for Ex Vivo and In Vivo Applications, May 12, 4 PM
Sponsored Symposium by Sartorius A Collaborative Approach to Enabling Efficient LV Manufacturing for Ex Vivo and In Vivo Gene Therapies, May 12, 4:30 PM





































